<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150210021029N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-17</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Propolis Gel under Dressing of periodontal flap surgery</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of Propolis Gel Under the Periodontal Dressing (Coe-Pack® GC America INC) on Gingival Healing Index After Periodontal Flap Surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-05-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/47956</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Single, Purpose: Treatment, Randomization description: Participants in the study were selected by Simple Randomization method, individually and with Random number table tools. The intervention was performed as Split-Mouth, and the choice of Quadrant for Intervention or Control was randomly performed with Coin instruments, Blinding description: Participant: In this study, due to the presence of surgical Drapes, it is not possible to detect the direction in which the Propolis and Placebo are
located
Data Analyzer: Data is evaluated as a number without specifying the position of the Propolis and the Placebo
Researcher and evaluator: The first side of each person is selected by the  flip coin method and put in group A, which is aware of the clinical caregiver, and the other side is in group B. gel and placebo have A and B labels.</study_design>
      <phase>3</phase>
      <hc_freetext>Periodontal flap surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After the surgery, we use the 20% Propolis gel, which is made by the Company that produces the Propolis (Green Plants of Life Company) under the Coe Pack( GC America inc), and then we mix the Coe Pack completely and place it on the surgical site. Intervention 2: Control group: After the periodontal flap surgery, we put the Placebo gel and then put the Coe Pack( GC America inc) dressing on the desired place.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Document Title: Data related to Personal information and Indicators examined in the study.
All Data can be shared after People have not been identified

When:
Up to One year after publication of the Article

To whom:
Researchers working in Academic and Scientific Institutions

Conditions:
In addition to mentioning the Name and Academic affiliation, the Applicant must have signed a letter stating that He or She does not intend to publish or use any of our study Data in Person

Where to obtain:
Applicants can contact this E-mail:
skiani.dnt@gmail.com

How to obtain:
The Project Manager will provide the requested Documents via E-mail no later than One week after receiving the E-mail from the Applicant

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sima Kiani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, Isfahan University of Medical Sciences, Hezarjerib Ave, Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7346181746</zip>
        <telephone>+98 31 3792 5542</telephone>
        <email>skiani.dnt@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sima Kiani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, Isfahan University of Medical Sciences, Hezarjerib Ave, Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7346181746</zip>
        <telephone>+98 31 3792 5542</telephone>
        <email>skiani.dnt@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with moderate to severe chronic Periodontitis require two side or whole mouth periodontal flap surgery that is systemically healthy
The same type of flap on both sides in each person
Age over 18 years
Pelaque index ≤ 1 after health education
No contraindications for surgery
No need to cut more than 2 mm of bone
No need for prophylactic Antibiotics
Do not take Corticosteroids or Hormones for the past two months
Having acceptable cooperation</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Smoking
Pregnancy
Taking anti-inflammatory drugs or Antibiotics
Existence of systemic disease
Pelaque index 2 or 3 after health education
Need to cut more than 2 mm of bone
Lack of cooperation and patient satisfaction</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K05.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Periodontal disease, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After the surgery, we use the 20% Propolis gel, which is made by the Company that produces the Propolis (Green Plants of Life Company) under the Coe Pack( GC America inc), and then we mix the Coe Pack completely and place it on the surgical site.</i_keyword>
      <i_keyword>Control group: After the periodontal flap surgery, we put the Placebo gel and then put the Coe Pack( GC America inc) dressing on the desired place</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Gingival healing index. Timepoint: One week after surgery, Two weeks after surgery, One month after surgery. Method of measurement: The healing rate is assessed based on tissue color, probe bleeding, granular tissue, cut margin, and discharge with five excellent, very good, good, weak, and very weak words.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pelaque index. Timepoint: Before surgery, One week after surgery, Two weeks after surgery and One month after surgery. Method of measurement: Based on the Silness and Loe method, it is evaluated in which the absence of Plaque(grade 0) to very large Plaque(grade 3) is ranked.</sec_outcome>
      <sec_outcome>Papillary bleeding index. Timepoint: Before surgery, One week after surgery, Two weeks after surgery and One month after surgery. Method of measurement: It shows the rate of papillary bleeding by probe in 4 ranks, from non-bleeding (grade 0) to spontaneous bleeding (grade 3).</sec_outcome>
      <sec_outcome>Pain index. Timepoint: Before surgery, One week after surgery, Two weeks after surgery and One month after surgery. Method of measurement: By the Visual Analog Scale form.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-02-25</approval_date>
        <contact_name>Ethics Committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Isfahan university of medical sciences, Hezarjerib Ave, Isfahan Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
